Human recombinant soluble ACE2 in severe COVID-19
Gespeichert in:
| Veröffentlicht in: | The lancet respiratory medicine 2020-11, Vol.8 (11), p.1154-1158 |
|---|---|
| Hauptverfasser: | , , , , , , , , , , , , , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 1158 |
|---|---|
| container_issue | 11 |
| container_start_page | 1154 |
| container_title | The lancet respiratory medicine |
| container_volume | 8 |
| creator | Zoufaly, Alexander Poglitsch, Marko Aberle, Judith H Hoepler, Wolfgang Seitz, Tamara Traugott, Marianna Grieb, Alexander Pawelka, Erich Laferl, Hermann Wenisch, Christoph Neuhold, Stephanie Haider, Doris Stiasny, Karin Bergthaler, Andreas Puchhammer-Stoeckl, Elisabeth Mirazimi, Ali Montserrat, Nuria Zhang, Haibo Slutsky, Arthur S Penninger, Josef M |
| description | |
| doi_str_mv | 10.1016/S2213-2600(20)30418-5 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_swepu</sourceid><recordid>TN_cdi_swepub_primary_oai_swepub_ki_se_466933</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S2213260020304185</els_id><sourcerecordid>2456857073</sourcerecordid><originalsourceid>FETCH-LOGICAL-c585t-89e856a9eab746e4302e4dbad8d88f02a45220f33f0bc1f5afe17a71978c8693</originalsourceid><addsrcrecordid>eNqFUUtLxDAQDqKoqD9B6VEP1cmrTS-KrOsDBA-K15CmU432oUm74r83666Lnswlw8z3GOYjZJ_CMQWandwzRnnKMoBDBkccBFWpXCPbyzYt1lc1wBbZC-EF4lNKMBCbZItzymkGxTah12NrusSj7dvSdaYbktA3Y9lgcj6ZssR1ScAZekwmd483FyktdslGbZqAe8t_hzxcTh8m1-nt3dXN5Pw2tVLJIVUFKpmZAk2ZiwwFB4aiKk2lKqVqYEZIxqDmvIbS0lqaGmluclrkyqqs4DskXciGD3wbS_3mXWv8p-6N08vWa6xQiyyiecSfLvBx0mJlsRu8af7Q_k4696yf-pnOJZVS5VHgcCng-_cRw6BbFyw2jemwH4NmQmZK5pDPveQCan0fgsd6ZUNBzwPS3wHp-fU1A_0dkJaRd_B7xxXrJ44IOFsAMB525tDrYB12FisXExp01bt_LL4A5uueZA</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2456857073</pqid></control><display><type>article</type><title>Human recombinant soluble ACE2 in severe COVID-19</title><source>MEDLINE</source><source>Alma/SFX Local Collection</source><source>SWEPUB Freely available online</source><creator>Zoufaly, Alexander ; Poglitsch, Marko ; Aberle, Judith H ; Hoepler, Wolfgang ; Seitz, Tamara ; Traugott, Marianna ; Grieb, Alexander ; Pawelka, Erich ; Laferl, Hermann ; Wenisch, Christoph ; Neuhold, Stephanie ; Haider, Doris ; Stiasny, Karin ; Bergthaler, Andreas ; Puchhammer-Stoeckl, Elisabeth ; Mirazimi, Ali ; Montserrat, Nuria ; Zhang, Haibo ; Slutsky, Arthur S ; Penninger, Josef M</creator><creatorcontrib>Zoufaly, Alexander ; Poglitsch, Marko ; Aberle, Judith H ; Hoepler, Wolfgang ; Seitz, Tamara ; Traugott, Marianna ; Grieb, Alexander ; Pawelka, Erich ; Laferl, Hermann ; Wenisch, Christoph ; Neuhold, Stephanie ; Haider, Doris ; Stiasny, Karin ; Bergthaler, Andreas ; Puchhammer-Stoeckl, Elisabeth ; Mirazimi, Ali ; Montserrat, Nuria ; Zhang, Haibo ; Slutsky, Arthur S ; Penninger, Josef M</creatorcontrib><identifier>ISSN: 2213-2600</identifier><identifier>EISSN: 2213-2619</identifier><identifier>DOI: 10.1016/S2213-2600(20)30418-5</identifier><identifier>PMID: 33131609</identifier><language>eng</language><publisher>England: Elsevier Ltd</publisher><subject>Angiotensin II - blood ; Angiotensin-Converting Enzyme 2 ; Betacoronavirus ; Biomarkers - blood ; Case Report ; Coronavirus Infections - therapy ; COVID-19 ; Female ; Humans ; Middle Aged ; Pandemics ; Peptidyl-Dipeptidase A - therapeutic use ; Pneumonia, Viral - therapy ; Recombinant Proteins - therapeutic use ; SARS-CoV-2</subject><ispartof>The lancet respiratory medicine, 2020-11, Vol.8 (11), p.1154-1158</ispartof><rights>2020 Elsevier Ltd</rights><rights>2020 Elsevier Ltd. All rights reserved. 2020 Elsevier Ltd</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c585t-89e856a9eab746e4302e4dbad8d88f02a45220f33f0bc1f5afe17a71978c8693</citedby><cites>FETCH-LOGICAL-c585t-89e856a9eab746e4302e4dbad8d88f02a45220f33f0bc1f5afe17a71978c8693</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>230,314,550,776,780,881,27901,27902</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/33131609$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink><backlink>$$Uhttp://kipublications.ki.se/Default.aspx?queryparsed=id:145181913$$DView record from Swedish Publication Index$$Hfree_for_read</backlink></links><search><creatorcontrib>Zoufaly, Alexander</creatorcontrib><creatorcontrib>Poglitsch, Marko</creatorcontrib><creatorcontrib>Aberle, Judith H</creatorcontrib><creatorcontrib>Hoepler, Wolfgang</creatorcontrib><creatorcontrib>Seitz, Tamara</creatorcontrib><creatorcontrib>Traugott, Marianna</creatorcontrib><creatorcontrib>Grieb, Alexander</creatorcontrib><creatorcontrib>Pawelka, Erich</creatorcontrib><creatorcontrib>Laferl, Hermann</creatorcontrib><creatorcontrib>Wenisch, Christoph</creatorcontrib><creatorcontrib>Neuhold, Stephanie</creatorcontrib><creatorcontrib>Haider, Doris</creatorcontrib><creatorcontrib>Stiasny, Karin</creatorcontrib><creatorcontrib>Bergthaler, Andreas</creatorcontrib><creatorcontrib>Puchhammer-Stoeckl, Elisabeth</creatorcontrib><creatorcontrib>Mirazimi, Ali</creatorcontrib><creatorcontrib>Montserrat, Nuria</creatorcontrib><creatorcontrib>Zhang, Haibo</creatorcontrib><creatorcontrib>Slutsky, Arthur S</creatorcontrib><creatorcontrib>Penninger, Josef M</creatorcontrib><title>Human recombinant soluble ACE2 in severe COVID-19</title><title>The lancet respiratory medicine</title><addtitle>Lancet Respir Med</addtitle><subject>Angiotensin II - blood</subject><subject>Angiotensin-Converting Enzyme 2</subject><subject>Betacoronavirus</subject><subject>Biomarkers - blood</subject><subject>Case Report</subject><subject>Coronavirus Infections - therapy</subject><subject>COVID-19</subject><subject>Female</subject><subject>Humans</subject><subject>Middle Aged</subject><subject>Pandemics</subject><subject>Peptidyl-Dipeptidase A - therapeutic use</subject><subject>Pneumonia, Viral - therapy</subject><subject>Recombinant Proteins - therapeutic use</subject><subject>SARS-CoV-2</subject><issn>2213-2600</issn><issn>2213-2619</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>D8T</sourceid><recordid>eNqFUUtLxDAQDqKoqD9B6VEP1cmrTS-KrOsDBA-K15CmU432oUm74r83666Lnswlw8z3GOYjZJ_CMQWandwzRnnKMoBDBkccBFWpXCPbyzYt1lc1wBbZC-EF4lNKMBCbZItzymkGxTah12NrusSj7dvSdaYbktA3Y9lgcj6ZssR1ScAZekwmd483FyktdslGbZqAe8t_hzxcTh8m1-nt3dXN5Pw2tVLJIVUFKpmZAk2ZiwwFB4aiKk2lKqVqYEZIxqDmvIbS0lqaGmluclrkyqqs4DskXciGD3wbS_3mXWv8p-6N08vWa6xQiyyiecSfLvBx0mJlsRu8af7Q_k4696yf-pnOJZVS5VHgcCng-_cRw6BbFyw2jemwH4NmQmZK5pDPveQCan0fgsd6ZUNBzwPS3wHp-fU1A_0dkJaRd_B7xxXrJ44IOFsAMB525tDrYB12FisXExp01bt_LL4A5uueZA</recordid><startdate>20201101</startdate><enddate>20201101</enddate><creator>Zoufaly, Alexander</creator><creator>Poglitsch, Marko</creator><creator>Aberle, Judith H</creator><creator>Hoepler, Wolfgang</creator><creator>Seitz, Tamara</creator><creator>Traugott, Marianna</creator><creator>Grieb, Alexander</creator><creator>Pawelka, Erich</creator><creator>Laferl, Hermann</creator><creator>Wenisch, Christoph</creator><creator>Neuhold, Stephanie</creator><creator>Haider, Doris</creator><creator>Stiasny, Karin</creator><creator>Bergthaler, Andreas</creator><creator>Puchhammer-Stoeckl, Elisabeth</creator><creator>Mirazimi, Ali</creator><creator>Montserrat, Nuria</creator><creator>Zhang, Haibo</creator><creator>Slutsky, Arthur S</creator><creator>Penninger, Josef M</creator><general>Elsevier Ltd</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope><scope>ADTPV</scope><scope>AOWAS</scope><scope>D8T</scope><scope>ZZAVC</scope></search><sort><creationdate>20201101</creationdate><title>Human recombinant soluble ACE2 in severe COVID-19</title><author>Zoufaly, Alexander ; Poglitsch, Marko ; Aberle, Judith H ; Hoepler, Wolfgang ; Seitz, Tamara ; Traugott, Marianna ; Grieb, Alexander ; Pawelka, Erich ; Laferl, Hermann ; Wenisch, Christoph ; Neuhold, Stephanie ; Haider, Doris ; Stiasny, Karin ; Bergthaler, Andreas ; Puchhammer-Stoeckl, Elisabeth ; Mirazimi, Ali ; Montserrat, Nuria ; Zhang, Haibo ; Slutsky, Arthur S ; Penninger, Josef M</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c585t-89e856a9eab746e4302e4dbad8d88f02a45220f33f0bc1f5afe17a71978c8693</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>Angiotensin II - blood</topic><topic>Angiotensin-Converting Enzyme 2</topic><topic>Betacoronavirus</topic><topic>Biomarkers - blood</topic><topic>Case Report</topic><topic>Coronavirus Infections - therapy</topic><topic>COVID-19</topic><topic>Female</topic><topic>Humans</topic><topic>Middle Aged</topic><topic>Pandemics</topic><topic>Peptidyl-Dipeptidase A - therapeutic use</topic><topic>Pneumonia, Viral - therapy</topic><topic>Recombinant Proteins - therapeutic use</topic><topic>SARS-CoV-2</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Zoufaly, Alexander</creatorcontrib><creatorcontrib>Poglitsch, Marko</creatorcontrib><creatorcontrib>Aberle, Judith H</creatorcontrib><creatorcontrib>Hoepler, Wolfgang</creatorcontrib><creatorcontrib>Seitz, Tamara</creatorcontrib><creatorcontrib>Traugott, Marianna</creatorcontrib><creatorcontrib>Grieb, Alexander</creatorcontrib><creatorcontrib>Pawelka, Erich</creatorcontrib><creatorcontrib>Laferl, Hermann</creatorcontrib><creatorcontrib>Wenisch, Christoph</creatorcontrib><creatorcontrib>Neuhold, Stephanie</creatorcontrib><creatorcontrib>Haider, Doris</creatorcontrib><creatorcontrib>Stiasny, Karin</creatorcontrib><creatorcontrib>Bergthaler, Andreas</creatorcontrib><creatorcontrib>Puchhammer-Stoeckl, Elisabeth</creatorcontrib><creatorcontrib>Mirazimi, Ali</creatorcontrib><creatorcontrib>Montserrat, Nuria</creatorcontrib><creatorcontrib>Zhang, Haibo</creatorcontrib><creatorcontrib>Slutsky, Arthur S</creatorcontrib><creatorcontrib>Penninger, Josef M</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><collection>SwePub</collection><collection>SwePub Articles</collection><collection>SWEPUB Freely available online</collection><collection>SwePub Articles full text</collection><jtitle>The lancet respiratory medicine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Zoufaly, Alexander</au><au>Poglitsch, Marko</au><au>Aberle, Judith H</au><au>Hoepler, Wolfgang</au><au>Seitz, Tamara</au><au>Traugott, Marianna</au><au>Grieb, Alexander</au><au>Pawelka, Erich</au><au>Laferl, Hermann</au><au>Wenisch, Christoph</au><au>Neuhold, Stephanie</au><au>Haider, Doris</au><au>Stiasny, Karin</au><au>Bergthaler, Andreas</au><au>Puchhammer-Stoeckl, Elisabeth</au><au>Mirazimi, Ali</au><au>Montserrat, Nuria</au><au>Zhang, Haibo</au><au>Slutsky, Arthur S</au><au>Penninger, Josef M</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Human recombinant soluble ACE2 in severe COVID-19</atitle><jtitle>The lancet respiratory medicine</jtitle><addtitle>Lancet Respir Med</addtitle><date>2020-11-01</date><risdate>2020</risdate><volume>8</volume><issue>11</issue><spage>1154</spage><epage>1158</epage><pages>1154-1158</pages><issn>2213-2600</issn><eissn>2213-2619</eissn><cop>England</cop><pub>Elsevier Ltd</pub><pmid>33131609</pmid><doi>10.1016/S2213-2600(20)30418-5</doi><tpages>5</tpages><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 2213-2600 |
| ispartof | The lancet respiratory medicine, 2020-11, Vol.8 (11), p.1154-1158 |
| issn | 2213-2600 2213-2619 |
| language | eng |
| recordid | cdi_swepub_primary_oai_swepub_ki_se_466933 |
| source | MEDLINE; Alma/SFX Local Collection; SWEPUB Freely available online |
| subjects | Angiotensin II - blood Angiotensin-Converting Enzyme 2 Betacoronavirus Biomarkers - blood Case Report Coronavirus Infections - therapy COVID-19 Female Humans Middle Aged Pandemics Peptidyl-Dipeptidase A - therapeutic use Pneumonia, Viral - therapy Recombinant Proteins - therapeutic use SARS-CoV-2 |
| title | Human recombinant soluble ACE2 in severe COVID-19 |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-29T01%3A28%3A14IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_swepu&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Human%20recombinant%20soluble%20ACE2%20in%20severe%20COVID-19&rft.jtitle=The%20lancet%20respiratory%20medicine&rft.au=Zoufaly,%20Alexander&rft.date=2020-11-01&rft.volume=8&rft.issue=11&rft.spage=1154&rft.epage=1158&rft.pages=1154-1158&rft.issn=2213-2600&rft.eissn=2213-2619&rft_id=info:doi/10.1016/S2213-2600(20)30418-5&rft_dat=%3Cproquest_swepu%3E2456857073%3C/proquest_swepu%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2456857073&rft_id=info:pmid/33131609&rft_els_id=S2213260020304185&rfr_iscdi=true |